Latest news
Loading news…
Arisaph Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Boston, Massachusetts, United States Founded 1999 11-50 employees For Profit
Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
3
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- Active products
- 6
- Patents granted
- 3
- Trademarks
- 4
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 1999
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 6
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Closed
- Dec 31, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 2.4
- Trend (90d)
- 1.1
Key People at Arisaph Pharmaceuticals
Co-Founder, Executive Vice President and Chief Scientist
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Arisaph Pharmaceuticals
Loading news…
FAQs about Arisaph Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.